임플란트 주위염 시장 예측(2026-2032년)

The Peri-implantitis Market is projected to grow by USD 1.90 billion at a CAGR of 6.50% by 2032.

Peri-implantitis Executive Summary

Peri-implantitis is a biofilm-associated, inflammatory condition affecting the tissues around dental implants, characterized by peri-implant mucosal inflammation and progressive loss of supporting bone. As dental implant therapy expands globally, peri-implant disease management has become a critical priority for dental clinicians, periodontists, oral surgeons, implant manufacturers, academic researchers, and healthcare payers. The condition is closely linked to plaque accumulation, prior periodontal disease, smoking, diabetes, inadequate maintenance, excess cement, prosthetic design limitations, and patient-specific immune responses. Current clinical attention is focused on early diagnosis, risk-based prevention, non-surgical debridement, regenerative and resective surgical approaches, implant surface decontamination, and long-term supportive peri-implant care. The peri-implantitis landscape is increasingly shaped by the need for evidence-based protocols, standardized case definitions, improved diagnostic accuracy, and therapies that preserve implant function while reducing recurrence. For stakeholders across oral healthcare, the opportunity lies in integrating prevention, digital monitoring, minimally invasive treatment, and patient adherence strategies into routine implant care pathways.

Transformative Shifts in the Peri-implantitis Landscape

The peri-implantitis landscape is undergoing transformative shifts driven by evolving clinical consensus, digital dentistry adoption, and a stronger emphasis on prevention. Historically, treatment approaches varied widely because disease definitions, severity grading, and outcome measures were inconsistent across clinical studies. The adoption of more standardized diagnostic frameworks has improved comparability and clinical decision-making, particularly around bleeding on probing, probing depth changes, suppuration, radiographic bone loss, and baseline implant records. At the same time, dental practices are moving from episodic intervention toward structured implant maintenance programs that include risk assessment, professional biofilm control, occlusal evaluation, and patient education. Treatment innovation is also reshaping care delivery. Air-abrasive decontamination, laser-assisted protocols, ultrasonic and titanium-compatible instrumentation, antiseptic adjuncts, local antimicrobials, regenerative biomaterials, and guided bone regeneration techniques are being evaluated to improve clinical outcomes. However, published evidence continues to show that no single modality is universally effective, reinforcing the importance of case selection, defect morphology, implant surface characteristics, and operator expertise. The shift toward personalized peri-implantitis management is therefore becoming central to clinical success.

Cumulative Impact of Artificial Intelligence on Peri-implantitis Care

Artificial intelligence is beginning to influence peri-implantitis prevention, diagnosis, workflow optimization, and clinical decision support. In implant dentistry, AI-enabled image analysis is being explored to support detection of marginal bone level changes on radiographs and cone-beam computed tomography images, helping clinicians identify early peri-implant bone loss more consistently. Machine learning models can also assist in risk stratification by combining clinical variables such as smoking status, history of periodontitis, glycemic control, plaque scores, bleeding indicators, implant location, prosthetic design, and maintenance compliance. The cumulative impact of AI is most meaningful when it strengthens-not replaces-clinical judgment. AI-supported charting, radiographic comparison, automated recall prioritization, and patient communication tools can improve follow-up consistency, which is essential because peri-implantitis is often detected after clinically meaningful tissue destruction has already occurred. In research settings, AI can accelerate evidence synthesis, phenotype classification, and analysis of large clinical datasets. Still, implementation must address data quality, algorithm validation, regulatory expectations, interoperability, bias mitigation, and transparent clinical governance before AI can become a routine standard in peri-implant disease management.

Key Regional Insights for Peri-implantitis

Asia-Pacific is experiencing rising clinical attention to peri-implantitis as dental implant adoption increases across urban centers and as specialty periodontal and prosthodontic services expand. Japan, South Korea, China, India, and Australia are advancing digital implant workflows, but access to standardized maintenance programs varies substantially between metropolitan and rural settings. North America is characterized by strong integration of implant dentistry into private dental practice, broad use of radiographic monitoring, and growing emphasis on risk-based recall programs, particularly for patients with diabetes, smoking exposure, or a history of periodontitis. Latin America shows increasing demand for implant rehabilitation and aesthetic dentistry, with Brazil and Mexico serving as important clinical education and treatment hubs; however, affordability and continuity of follow-up remain important determinants of peri-implantitis outcomes. Europe benefits from mature periodontal research networks, structured clinical guidelines, and high awareness of implant maintenance, with strong emphasis on evidence-based diagnosis and supportive peri-implant therapy. The Middle East is seeing rapid development of advanced dental clinics, especially in high-income Gulf markets, where digital dentistry and specialist-led implant care are increasingly common. Across Africa, implant dentistry is expanding unevenly, with access concentrated in private urban clinics; workforce training, cost barriers, and preventive maintenance infrastructure are central issues affecting peri-implantitis management.

Key Group Insights for Peri-implantitis

ASEAN countries are seeing growing demand for dental implants through expanding middle-class access, dental tourism, and private clinic investment, making peri-implantitis prevention increasingly relevant as long-term implant maintenance becomes a differentiator in care quality. In the GCC, high investment in premium dental services, digital imaging, and specialist-led care supports advanced diagnosis and treatment, while lifestyle-related risk factors such as diabetes heighten the need for structured peri-implant monitoring. The European Union provides a strong regulatory and clinical environment for evidence-based implant dentistry, with increasing alignment around quality systems, continuing professional education, and patient safety standards. BRICS countries show diverse peri-implantitis dynamics: China and India are scaling implant access rapidly, Brazil has a strong oral healthcare and implant training ecosystem, Russia maintains demand for implant rehabilitation across major cities, and South Africa reflects a more concentrated private-sector implant base. G7 countries generally demonstrate higher availability of specialist periodontal care, digital workflows, and maintenance protocols, but they also face aging populations and rising chronic disease burdens that complicate implant outcomes. NATO member countries overlap significantly with advanced dental markets in North America and Europe, where clinical readiness, academic research, and regulatory maturity support broader adoption of peri-implantitis diagnostic and treatment protocols.

Key Country Insights for Peri-implantitis

The United States has a highly developed implant dentistry ecosystem, with peri-implantitis management increasingly tied to periodontal risk assessment, radiographic surveillance, and maintenance compliance. Canada shows strong clinical awareness and preventive care standards, though access can vary by province and insurance coverage. Mexico combines domestic implant demand with cross-border dental care, making continuity of maintenance an important consideration. Brazil has one of the most active implant dentistry environments in Latin America, supported by specialist education and broad clinical experience, while patient adherence to long-term maintenance remains essential. The United Kingdom emphasizes evidence-based dental care and guideline-driven periodontal management, with peri-implant disease increasingly incorporated into specialist referral pathways. Germany, France, Italy, and Spain all demonstrate mature implant markets with strong professional education, digital dentistry adoption, and growing attention to supportive peri-implant therapy. Russia has significant urban demand for implant rehabilitation, with advanced care concentrated in major dental centers. China is rapidly expanding implant access through urban dental networks and digital technology adoption, creating a growing need for standardized peri-implantitis diagnosis and maintenance. India is experiencing increasing implant uptake in private practices, but variability in follow-up systems influences disease prevention. Japan faces an aging population with high restorative needs, making peri-implant health monitoring particularly important. Australia shows strong alignment with preventive dentistry and specialist periodontal care, while South Korea combines advanced digital dentistry, high clinical sophistication, and strong patient demand for implant-supported rehabilitation.

Actionable Recommendations for Peri-implantitis Industry Leaders

Industry leaders should prioritize prevention-first peri-implant care models that begin before implant placement and continue throughout the implant lifecycle. Dental professionals and solution providers should support standardized risk assessment covering periodontal history, smoking, diabetes control, plaque control, occlusion, keratinized mucosa, implant position, and prosthetic cleanability. Clinical teams should document baseline probing depths and radiographs after prosthesis delivery to improve future diagnosis. Education programs must reinforce that peri-implant mucositis is reversible when addressed early, while peri-implantitis requires more complex intervention and long-term maintenance. Manufacturers and clinical innovators should focus on implant and prosthetic designs that improve hygiene access, reduce plaque-retentive features, and support retrievability when maintenance or repair is needed. Digital platforms should be used to improve recall adherence, radiographic comparison, patient reminders, and outcome tracking. Treatment providers should adopt evidence-based, defect-specific protocols rather than relying on a single device or adjunctive therapy. Research leaders should invest in robust comparative clinical studies with standardized definitions, patient-reported outcomes, and long-term follow-up to strengthen clinical confidence in peri-implantitis interventions.

Research Methodology

This executive summary is based on a structured review of verified clinical, regulatory, academic, and public health sources related to peri-implantitis, peri-implant mucositis, dental implant maintenance, periodontal risk factors, diagnostic criteria, and treatment approaches. The methodology emphasizes evidence from peer-reviewed dental and periodontal literature, consensus workshop outputs, clinical practice guidelines, systematic reviews, and recognized public health and professional education resources. Insights were synthesized qualitatively to identify disease drivers, care pathway shifts, regional practice patterns, technology adoption trends, and evidence gaps. Regional, group, and country insights were developed by assessing oral healthcare infrastructure, implant dentistry adoption, specialist availability, digital dentistry maturity, chronic disease relevance, affordability considerations, and continuity of care challenges. The analysis intentionally excludes market sizing, revenue estimation, share calculation, and forecasting. The resulting perspective is designed to support strategic decision-making for stakeholders seeking to improve peri-implantitis prevention, diagnosis, treatment standardization, and long-term implant success.

Conclusion

Peri-implantitis is increasingly recognized as a major clinical challenge in modern implant dentistry, requiring coordinated action across prevention, diagnostics, treatment innovation, and patient maintenance. The most effective strategies are likely to combine standardized assessment, early identification of peri-implant mucositis, individualized risk management, and defect-specific therapy supported by consistent follow-up. Digital dentistry and artificial intelligence can improve monitoring and workflow efficiency, but their value depends on validated tools, high-quality data, and responsible clinical integration. Regional differences in access, training, reimbursement, and maintenance infrastructure will continue to influence outcomes, making localized strategies essential. For industry leaders, the path forward is clear: strengthen prevention, design for maintainability, support clinician education, generate higher-quality evidence, and empower patients to participate in lifelong implant care. By aligning innovation with evidence-based peri-implant health management, the dental ecosystem can reduce complications, preserve implant function, and improve long-term patient outcomes.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Definition
• 1.3. Market Segmentation & Coverage
• 1.4. Years Considered for the Study
• 1.5. Currency Considered for the Study
• 1.6. Language Considered for the Study
• 1.7. Key Stakeholders

2. Research Methodology

• 2.1. Introduction
• 2.2. Research Design
  • 2.2.1. Primary Research
  • 2.2.2. Secondary Research
• 2.3. Research Framework
  • 2.3.1. Qualitative Analysis
  • 2.3.2. Quantitative Analysis
• 2.4. Market Size Estimation
  • 2.4.1. Top-Down Approach
  • 2.4.2. Bottom-Up Approach
• 2.5. Data Triangulation
• 2.6. Research Outcomes
• 2.7. Research Assumptions
• 2.8. Research Limitations

3. Executive Summary

• 3.1. Introduction
• 3.2. CXO Perspective
• 3.3. Market Size & Growth Trends
• 3.4. New Revenue Opportunities
• 3.5. Next-Generation Business Models
• 3.6. Industry Roadmap

4. Market Overview

• 4.1. Introduction
• 4.2. Industry Ecosystem & Value Chain Analysis
  • 4.2.1. Supply-Side Analysis
  • 4.2.2. Demand-Side Analysis
  • 4.2.3. Stakeholder Analysis
• 4.3. Market Dynamics
  • 4.3.1. Key Drivers
  • 4.3.2. Key Restraints
  • 4.3.3. Key Opportunities
  • 4.3.4. Key Challenges
• 4.4. Porter's Five Forces Analysis
• 4.5. PESTLE Analysis
• 4.6. Market Outlook
  • 4.6.1. Near-Term Market Outlook (0-2 Years)
  • 4.6.2. Medium-Term Market Outlook (3-5 Years)
  • 4.6.3. Long-Term Market Outlook (5-10 Years)
• 4.7. Go-to-Market Strategy

5. Market Insights

• 5.1. Consumer Insights & End-User Perspective
• 5.2. Consumer Experience Benchmarking
• 5.3. Opportunity Mapping
• 5.4. Distribution Channel Analysis
• 5.5. Pricing Trend Analysis
• 5.6. Regulatory Compliance & Standards Framework
• 5.7. ESG & Sustainability Analysis
• 5.8. Disruption & Risk Scenarios
• 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Peri-implantitis Market, by Product Type

• 7.1. Introduction
• 7.2. Adjunctive Devices
• 7.3. Laser Treatment
• 7.4. Pharmacological Treatment
• 7.5. Surgical Treatment
  • 7.5.1. Graft Type
    • 7.5.1.1. Allograft
    • 7.5.1.2. Autograft
    • 7.5.1.3. Synthetic
    • 7.5.1.4. Xenograft
  • 7.5.2. Membrane Type
    • 7.5.2.1. Non-Resorbable
    • 7.5.2.2. Resorbable

8. Peri-implantitis Market, by Treatment Modality

• 8.1. Introduction
• 8.2. Non Surgical
  • 8.2.1. Local Antibiotic Therapy
  • 8.2.2. Mechanical Debridement
• 8.3. Surgical
  • 8.3.1. Regenerative Procedures
  • 8.3.2. Resective Procedures

9. Peri-implantitis Market, by Implant Material

• 9.1. Introduction
• 9.2. Titanium
• 9.3. Zirconia

10. Peri-implantitis Market, by Severity

• 10.1. Introduction
• 10.2. Mild
• 10.3. Moderate
• 10.4. Severe

11. Peri-implantitis Market, by End User

• 11.1. Introduction
• 11.2. Ambulatory Surgery Centers
• 11.3. Dental Clinics
• 11.4. Hospitals

12. Peri-implantitis Market, by Distribution Channel

• 12.1. Introduction
• 12.2. Offline
• 12.3. Online

13. Peri-implantitis Market, by Region

• 13.1. Asia-Pacific
• 13.2. North America
• 13.3. Latin America
• 13.4. Europe
• 13.5. Middle East
• 13.6. Africa

14. Peri-implantitis Market, by Group

• 14.1. ASEAN
• 14.2. GCC
• 14.3. European Union
• 14.4. BRICS
• 14.5. G7
• 14.6. NATO

15. Peri-implantitis Market, by Country

• 15.1. United States
• 15.2. Canada
• 15.3. Mexico
• 15.4. Brazil
• 15.5. United Kingdom
• 15.6. Germany
• 15.7. France
• 15.8. Russia
• 15.9. Italy
• 15.10. Spain
• 15.11. China
• 15.12. India
• 15.13. Japan
• 15.14. Australia
• 15.15. South Korea

16. Competitive Landscape

• 16.1. Market Share Analysis, 2025
• 16.2. FPNV Positioning Matrix, 2025
• 16.3. Market Concentration Analysis, 2025
  • 16.3.1. Concentration Ratio (CR)
  • 16.3.2. Herfindahl Hirschman Index (HHI)
• 16.4. Recent Developments & Impact Analysis, 2025
• 16.5. Product Portfolio Analysis, 2025
• 16.6. Benchmarking Analysis, 2025

17. Company Profiles

• 17.1. BEGO GmbH & Co. KG
• 17.2. Botiss biomaterials GmbH
• 17.3. Dentium Co., Ltd.
• 17.4. Dentsply Sirona Inc.
• 17.5. Freiburger Medizintechnik GmbH
• 17.6. GalvoSurge Dental AG
• 17.7. GC Corporation
• 17.8. Geistlich Pharma AG
• 17.9. Henry Schein, Inc.
• 17.10. Institut Straumann AG
• 17.11. Megagen Implant Co., Ltd.
• 17.12. Nobel Biocare Services AG
• 17.13. Southern Implants (Pty) Ltd
• 17.14. W&H Dentalwerk Burmoos GmbH
• 17.15. ZimVie Inc.